ALPROLIX 500 IU, powder and solvent for solution for injection bottle, 5 ml
Active ingredients: Eftrenonacog alfa
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALPROLIX 500 UI, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 Boite de 1 flacon de 500 UI (en verre) + 1 seringue préremplie de 5 ml (100 UI/mL) + 1 piston de seringue + 1 adaptateur pour flacon + 1 kit de perfusion + 2 tampons alcoolisés + 2 pansements + 1 compresse de gaze
- Marketing authorisation holder
- SWEDISH ORPHAN BIOVITRUM (SUEDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Feb 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66430312CIP75502283CIP133400955022831Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| EFTRÉNONACOG ALFApoudre | 500 UI · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.